Millions More People with Overweight Could Benefit From GLP-1 Drugs to Protect Heart Health, Study Suggests

GLP-1 drugs: From weight loss wonder to potential heart-care tool

Clinical trials suggest GLP-1 drugs aid weight loss and may cut heart risks in overweight/obese patients, especially with established CVD; use with lifestyle and medical guidance.

Research makes strong case for broader use of GLP1 drugs to protect hearts

New research being presented at the annual meeting of the European Association for the Study of Diabetes (EASD) in Milan, Italy (Sept 28 – Oct 2) makes a case for extending the indication for GLP1- receptor agonists (GLP1-RAs) to millions more people, to protect their heart health.

Millions more people with overweight could benefit from GLP-1 drugs to protect heart health, study suggests

New research being presented at the annual meeting of the European Association for the Study of Diabetes (EASD) in Milan, Italy, Sept. 28–Oct. 2, makes a case for extending the indication for GLP-1 receptor agonists (GLP1-RAs) to millions more people to protect their heart health.